about
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virusMultimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.DNA vaccines for HIV: challenges and opportunities.Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells.Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccineCo-delivery of ccl19 gene enhances anti-caries DNA vaccine pCIA-P immunogenicity in mice by increasing dendritic cell migration to secondary lymphoid tissues.An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cellsHIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunityThe nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.Trial watch: Naked and vectored DNA-based anticancer vaccinesTechnologies for enhanced efficacy of DNA vaccines.Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation.Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunityThe efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.Ovarian cancer vaccine trials and tribulations.Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvantDNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells.Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines.Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice.Transcriptional IL-15-directed in vivo DC targeting DNA vaccine.B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccinesNovel approaches to tuberculosis prevention: DNA vaccines.Microneedles for vaccine delivery: challenges and future perspectives.Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.PMMA particle-mediated DNA vaccine for cervical cancer.N-glycan targeted gene delivery to the dendritic cell SIGN receptor.Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
P2860
Q24658311-F1DEFF69-7A4E-4B8C-9D57-474F9461DA8DQ27472925-EEB248A5-FD60-401E-AEA6-08045E602646Q30357322-5B0B40C0-5030-4BD9-B5AB-442717A7DCDAQ33601372-AC266F39-BD84-4536-85D1-8A1C4592DF71Q33732729-241B4089-358D-4354-894A-06952FF53547Q33779343-8956D6AE-A2CD-47D7-9EDE-7A46A3A53138Q33850497-FAC2F2D3-D837-47A6-A2FA-E93624C54935Q34555051-546B1416-874F-47D1-81D0-F15FC96F8A23Q34796885-2641B06C-C98C-44FF-A29A-0CE5801DB0DCQ35108680-9D36C8D8-582C-4386-8994-81D0B0D4CBFFQ35328544-D6C2F71F-BB88-45BC-8CF3-470CAE6DE360Q35628183-FCB7F10C-D30C-4B43-9C77-EA484D2BCF1BQ35661163-10BD6185-B5E2-4118-8407-17A5E9ED1335Q35750026-01B15BBC-2D20-4354-B14B-632AED3EE70CQ35798986-161DC10E-7DD2-4A62-8F99-3813D6F207D9Q35802958-5C7C0112-639B-49C5-82C6-C6E9F31D40EBQ35826698-6DEE2DAF-8F61-4616-8823-25812516209FQ35878909-6DF090DE-9100-45B9-A06A-F3A8D21999F7Q35946021-DD43FE71-8CCC-46CD-B82B-6A05C9F0967EQ36099003-E661F5A4-AFC9-44F4-9665-9AB81678E6DDQ36229051-2CA085C0-C9DC-47E8-8D67-4850806338BEQ36476095-360223D1-783C-43CB-AB63-E8A77A3ACB58Q36489528-18C82E21-C97B-4D5A-BCB7-0E962B1FD875Q36675457-4E6D1800-2604-47AC-88E6-D0B94D15F917Q36694830-871F5AA6-148F-4F9F-96B3-DF56B1D0E9F0Q36694851-81AD9F76-3647-4BA3-916C-E7C93E4A2F43Q36948581-C6945946-ECC7-461E-9F1B-66F2F3B89F49Q37309264-D4827510-ADA7-4EB1-B2C7-03AA437738FDQ37388709-D48C31BA-D44D-4851-B206-966F7F02B164Q37708724-7E0CFF95-1F94-429E-95FA-1891790D36A4Q38180804-B16B8B7F-8638-424D-9AD8-B573ADA90793Q38681048-717ABE47-707C-4131-8A4D-5B0FE5257E3BQ38847190-3869984D-4B3A-40A7-B3D2-13EE3D13E17FQ39320211-A01D7D48-1C2F-45D4-BBB9-CB0D23A2A5BCQ39607848-2B281A20-0EFA-4068-8F33-4A7373C438D9Q39708894-1C92CF86-F799-4F61-A08D-A48AB9D0FC97Q39999821-A0422460-9B02-4D7B-B558-14495D3A9215Q40958429-E6F48A44-FFC2-4F98-BEB7-F357FA6AEDD9Q42079721-C085587F-E253-44C9-9CA2-BDBB0DBEDC96Q45885513-19BA40D4-428B-47AF-A80C-39457CA9F120
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Developing DNA vaccines that call to dendritic cells.
@ast
Developing DNA vaccines that call to dendritic cells.
@en
type
label
Developing DNA vaccines that call to dendritic cells.
@ast
Developing DNA vaccines that call to dendritic cells.
@en
prefLabel
Developing DNA vaccines that call to dendritic cells.
@ast
Developing DNA vaccines that call to dendritic cells.
@en
P2860
P356
P1476
Developing DNA vaccines that call to dendritic cells.
@en
P2093
David B Weiner
Michele A Kutzler
P2860
P304
P356
10.1172/JCI23467
P407
P577
2004-11-01T00:00:00Z